CPSS's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CPSS turned positive on September 10, 2026. Looking at past instances where CPSS's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on CPSS as a result. In 81 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
CPSS moved above its 50-day moving average on September 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPSS advanced for three days, in 236 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
CPSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for CPSS crossed bearishly below the 50-day moving average on August 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 32 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.636) is normal, around the industry mean (4.234). P/E Ratio (10.352) is within average values for comparable stocks, (15.404). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.276). Dividend Yield (0.000) settles around the average of (0.081) among similar stocks. P/S Ratio (1.069) is also within normal values, averaging (5.928).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. CPSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.